Lombard Odier Asset Management (Switzerland)’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,016
Closed -$310K 296
2023
Q1
$310K Buy
+2,016
New +$333K 0.03% 338
2022
Q3
Sell
-1,607
Closed -$230K 321
2022
Q2
$230K Buy
+1,607
New +$230K 0.02% 298
2022
Q1
Sell
-1,809
Closed -$459K 308
2021
Q4
$459K Buy
+1,809
New +$529K 0.03% 254
2021
Q3
Sell
-2,164
Closed -$508K 382
2021
Q2
$508K Sell
2,164
-125,540
-98% -$22.4M 0.03% 320
2021
Q1
$16.7M Buy
+127,704
New +$18.5M 1.11% 34

Other funds holding MRNA

Lombard Odier Asset Management (Switzerland)'s MRNA Position: Q2 2023 in Review

Lombard Odier Asset Management (Switzerland) sold out of Moderna (MRNA) in Q2 2023, closing a stake of 2,016 shares — an estimated $310K sold.

Lombard Odier Asset Management (Switzerland) first reported a position in MRNA in Q1 2021 and held it in 5 quarters. The position peaked at $16.7M in Q1 2021. 967 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

  • Lombard Odier Asset Management (Switzerland) reported no remaining Moderna position as of Q2 2023 after selling out during the quarter.
  • Lombard Odier Asset Management (Switzerland) sold 2,016 Moderna shares in Q2 2023, an estimated $310K.
  • Lombard Odier Asset Management (Switzerland) first reported a position in Moderna in Q1 2021 and held it in 5 quarters.
  • Lombard Odier Asset Management (Switzerland)'s Moderna position peaked at $16.7M in Q1 2021.
  • 967 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 14 Aug 2023.